2013
DOI: 10.1093/nar/gkt1255
|View full text |Cite
|
Sign up to set email alerts
|

GPCRDB: an information system for G protein-coupled receptors

Abstract: For the past 20 years, the GPCRDB (G protein-coupled receptors database; http://www.gpcr.org/7tm/) has been a ‘one-stop shop’ for G protein-coupled receptor (GPCR)-related data. The GPCRDB contains experimental data on sequences, ligand-binding constants, mutations and oligomers, as well as many different types of computationally derived data, such as multiple sequence alignments and homology models. The GPCRDB also provides visualization and analysis tools, plus a number of query systems. In the latest GPCRDB… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
156
0
1

Year Published

2015
2015
2021
2021

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 135 publications
(157 citation statements)
references
References 20 publications
0
156
0
1
Order By: Relevance
“…This crystallographic structure was chosen in accordance with a total sequence similarity of 68%, as calculated with BLAST (10). In addition each TM was then aligned to the TMs of the template, which numeration was obtained at the GPCRdatabase (11). The TMs were checked for sequence similarity and a average value of 77 % was attained for this more relevant and conserved helical bundle.…”
Section: Modellingmentioning
confidence: 99%
“…This crystallographic structure was chosen in accordance with a total sequence similarity of 68%, as calculated with BLAST (10). In addition each TM was then aligned to the TMs of the template, which numeration was obtained at the GPCRdatabase (11). The TMs were checked for sequence similarity and a average value of 77 % was attained for this more relevant and conserved helical bundle.…”
Section: Modellingmentioning
confidence: 99%
“…In the case of the ß1 adrenergic receptor, as shown in Figure 10, the ligand carazolol (Moukhametzianov et al, 2011), bound entirely within the major pocket (panel A) alters signal exclusively to the G protein pathways, without influence on arrestin pathways. By contrast the larger ligand carvedilol, bound in both major and minor pockets of ß1 adrenergic receptor ( Figure 10, panel (Isberg et al, 2014).…”
Section: Ligand Binding: Extracellular Viewmentioning
confidence: 99%
“…In the case of the ß1 adrenergic receptor, as shown in Figure 10, the ligand carazolol (Moukhametzianov et al, 2011), bound entirely within the major pocket (panel A) alters signal exclusively to the G protein pathways, without influence on arrestin pathways. By contrast the larger ligand carvedilol, bound in both major and minor pockets of ß1 adrenergic receptor ( Figure 10, panel (Isberg et al, 2014).Representation modes that are effective for the extracellular view include both the schematic wheel/box diagrams and several three-dimensional representation modes. The twodimensional schematic wheel/box is effective to depict the contribution of specific amino acid residues in the context of each helix.…”
mentioning
confidence: 99%
“…In this paper, a new dataset was built from the latest version (updated at September 26, 2013) of GPCRDB [9]. The newly update GPCRDB classify all the protein sequences into six main families, (1) Class A Rhodopsin like, (2) Class B Secretin like, (3) Class C Metabotropic glutamate/pheromone family, (4) Class D cAMP receptors family, (5) Class E Vomeronasal receptors (V1R and V3R) family and (6) Class F Taste receptors T2R family.…”
Section: Datasetmentioning
confidence: 99%
“…In the area of GPCR, the GPCRDB is a molecular classspecific information system that collects, combines, validates and disseminates large amounts of heterogeneous data on GPCRs [8]. According to the latest release of GPCRDB, the data are grouped into six families based on the pharmacological classification of GPCRs [9]. These GPCRs families and their structural features are closely correlated with their function [1], it would be significant to develop a powerful computational method to classify GPCRs into particular families for the purpose of understanding their biological function and their potential as future drug targets.…”
Section: Introductionmentioning
confidence: 99%